Tammy Utset to Chemokine CXCL13
This is a "connection" page, showing publications Tammy Utset has written about Chemokine CXCL13.
Connection Strength
0.088
-
Unique Sjögren's syndrome patient subsets defined by molecular features. Rheumatology (Oxford). 2020 04 01; 59(4):860-868.
Score: 0.047
-
Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ß Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2018 09; 70(9):1470-1480.
Score: 0.041